Search

Search Constraints

You searched for: Author/Creator Uzzo, Robert

Search Results

1. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Issue 10358 (1st October 2022)

2. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. Issue 10 (1st April 2021)

3. Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. Issue 1 (22nd October 2019)

4. Impact of COVID-19 on Initial Management and Evaluation of Prostate Cancer. Issue 6 (23rd November 2021)

6. MP12-08 OUTCOMES OF NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH VENOUS THROMBUS FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER COLLABORATIVE STUDY. (May 2022)

7. MP31-05 LARGE SCALE IMPLEMENTATION OF OPIOID PRESCRIPTION REDUCTION AFTER ROBOTIC PROSTATECTOMY – 2 YEAR EVALUATION FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC). (May 2022)

8. MP40-06 ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATHOLOGICAL DOWNSTAGING DURING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP). (May 2022)

9. MP43-06 COMPARING MRI/US FUSION TO STANDARD PROSTATE BIOPSY IN DETERMINING GRADE RECLASSIFICATION AT CONFIRMATORY BIOPSY IN A MULTI-INSTITUTIONAL ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS. (1st May 2022)

10. MP43-16 RACIAL DISPARITIES IN RATES OF GLEASON GRADE RECLASSIFICATION IN A MULTI-INSTITUTIONAL PROSTATE CANCER ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS. (1st May 2022)